Senti Biosciences Inc share price logo

Senti Biosciences Inc Share Price

NASDAQ: SNTI

Small Cap

$1.35

as on

Senti Biosciences Inc Stock Performance

as on September 16, 2025 at 1:28 am IST

  • Day's Low

    Day's High

    $1.33
    $1.4
    downward going graph

    1.48%

    Downside

    3.70%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.26
    $16.94
    downward going graph

    6.67%

    Downside

    1154.81%

    Upside

    downward going graph

Senti Biosciences Inc share price movements today

Previous Close
$1.35
Open
$1.35
Volume
498.6K
Day's Low - High
$1.33 - $1.4
52 Week Low - High
$1.26 - $16.94

Senti Biosciences Inc Historical Returns

1 Month Return
-11.18 %
3 Month Return
-48.08 %
1 Year Return
-56.03 %
3 Year Return
-94 %
5 Year Return
0 %

Senti Biosciences Inc Stock Fundamentals & Key Indicators

Check Senti Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$35.3M

EPS (TTM)

-2.38

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.22

Industry PE ratio

-3.8535542168674697

P/B Ratio

0

PEG Ratio

0

EBITDA

-53.5M

Revenue (TTM)

338.0K

Profit Margin

0.00%

Return On Equity TTM

838200.00%

Senti Biosciences Inc Stock Valuation

Track how Senti Biosciences Inc P/E has moved over time to understand its valuation trends.

Senti Biosciences Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 15, 2025

Industry (-3.85x)

September 15, 2025

Today (-0.22x)

September 15, 2025

Highest (-0.28x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: -0.22x

Senti Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Senti Biosciences Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$35.3MNA-0.220.00%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Senti Biosciences Inc Stock including INR - Dollar returns

The Senti Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Senti Biosciences Inc investment value today

Current value as on today

₹48,959

Returns

₹51,041

(-51.04%)

Returns from Senti Biosciences Inc Stock

₹56,026 (-56.03%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Senti Biosciences Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Senti Biosciences Inc. Average target price of $13.5

Senti Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Senti Biosciences Inc.

What analysts predicted

90%UPSIDE

Target Price

$13.5

Current Price

$1.35

Analyzed by

7 Analysts

Target

$13.50

Senti Biosciences Inc target price $13.5, a slight upside of 90% compared to current price of $1.35. According to 7 analysts rating.

Senti Biosciences Inc Stock's Interest Amongst Investors

Search interest for Senti Biosciences Inc Stock has increased by 11% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:11% versus previous 30 day period

Senti Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
1
0
0
0
0
-
-
5
-
-
Gross Profit
-10
0
-25
-1
-1
-1
-
2
-
-1
Operating Income
-19
-19
-43
-18
-16
-13
-15
-16
-16
-16
EBITDA
-17
-17
-15
-16
-14
-11
-13
-5
-14
-13
Interest Expense
1
0
-
1
1
-
-
-
-
-
Depreciation
0
1
1
1
1
1
1
1
1
1
Income Before Tax
-18
-18
-36
-18
-12
-11
-28
0
-14
-14
Income Tax Expense
-1
-1
-2
0
0
-
-
0
-
-
Net Income
-18
-18
-14
-18
-12
-11
-28
0
-14
-14
Net Profit Margin
-1807.14%
-1995.41%
-5852.16%
-5620.42%
-3636.94%
0.00%
0.00%
-10.42%
0.00%
0.00%

Senti Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
0
2
4
2
-
Gross Profit
-14
-15
0
4
-2
-
Operating Income
-21
-24
-40
-70
-92
-61
EBITDA
-21
-22
-39
-66
-61
-46
Interest Expense
-
0
0
3
-
-
Depreciation
-
1
3
3
4
5
Income Before Tax
-21
-19
-55
-58
-83
-52
Income Tax Expense
-
0
0
-12
9
-
Net Income
-21
-19
-55
-45
-92
-52
Net Profit Margin
-24890.59%
-5041.12%
-2414.62%
-1068.39%
-3628.23%
0.00%

Senti Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-18
-14
-18
-12
-11
-28
0
-14
-14
Operating Cash Flow
-13
-15
-7
-11
-8
-7
-13
-14
-13
Investing Cash Flow
18
21
-
0
-
0
0
-
0
Financing Cash Flow
0
0
0
0
-
2
51
0
1
Change in Cash
4
5
-3
-12
-8
-5
37
-14
-12

Senti Biosciences Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-19
-55
-58
-71
-52
Operating Cash Flow
-24
-34
-34
-52
-41
Investing Cash Flow
11
-5
-81
30
0
Financing Cash Flow
38
68
118
0
53
Change in Cash
25
28
1
-21
12

Global Institutional Holdings in Senti Biosciences Inc

Funds
Holdings
NEA Management Company, LLC
14.48%
Nantahala Capital Management, LLC
3.4%
Heights Capital Management Inc
2.88%
Vanguard Group Inc
0.59%
UBS Group AG
0.17%

Insights on Senti Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 255.0K → 5.85M (in $), with an average increase of 39.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 131.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 217.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -610.0K → -14.73M (in $), with an average decrease of 1108.9% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, SNTI stock has moved down by -11.2%

About Senti Biosciences Inc

senti biosciences is a team of engineers, scientists, and entrepreneurs on a mission to leverage synthetic biology to treat the most pressing diseases. they have pioneered new technology platforms to design synthetic gene circuits for adaptive cell and gene therapies. their recently completed series a round of funding will be used to further the growth of their scalable therapeutic design platform and advance therapeutic candidates towards the clinic. they are proud to count nea, 8vc, amgen ventures, pear ventures, lux capital, menlo ventures, allen & company, nest.bio, omega funds, goodman capital, and lifeforce capital among their investors.
OrganisationSenti Biosciences Inc
Headquarters2 Corporate Drive, South San Francisco, CA, United States, 94080
IndustryFinancial
CEODr. Timothy K. Lu M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Senti Biosciences Inc

Name

Title

Mr. Faraz Siddiqui

Senior Vice President of Technical Operations

Mr. Thomas P. Chung

Vice President of Strategic Finance & Corporate Development

Ms. Dee Olomajeye Dragon

VP of People & Culture Strategy & Head of Administrative Operations

Dr. Kanya Rajangam M.D., Ph.D.

President, Head of Research & Development and Chief Medical Officer

Mr. Jay Cross

Chief Financial Officer

Dr. Wilson Wong Ph.D.

Scientific Co-Founder & Member of Scientific Advisory Board

Mr. Robert H. Cutler J.D.

Senior VP & Head of Legal Affairs

Dr. Timothy K. Lu M.D., Ph.D.

Co-Founder, CEO & Director

Dr. James J. Collins Ph.D.

Scientific Co-Founder, Chairperson of Scientific Advisory Board & Independent Director

FAQs

What is Senti Biosciences Inc share price today?

Senti Biosciences Inc share price today is $1.35 as on at the close of the market. Senti Biosciences Inc share today touched a day high of $1.4 and a low of $1.33.

What is the 52 week high and 52 week low for Senti Biosciences Inc share?

Senti Biosciences Inc share touched a 52 week high of $16.94 on and a 52 week low of $1.26 on . Senti Biosciences Inc stock price today i.e. is closed at $1.35,which is 92.03% down from its 52 week high and 7.14% up from its 52 week low.

What is Senti Biosciences Inc's market capitalisation today?

Senti Biosciences Inc market capitalisation is $0.00T as on .

How to invest in Senti Biosciences Inc Stock (SNTI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Senti Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Senti Biosciences Inc Shares that will get you 1.1111 shares as per Senti Biosciences Inc share price of $1.35 per share as on September 16, 2025 at 1:28 am IST.

What is the minimum amount required to buy Senti Biosciences Inc Stock (SNTI) from India?

Indian investors can start investing in Senti Biosciences Inc (SNTI) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Senti Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Senti Biosciences Inc share’s latest price of $1.35 as on September 16, 2025 at 1:28 am IST, you will get 7.4074 shares of Senti Biosciences Inc. Learn more about fractional shares .